An assessment of the documentation for 30 over-the-counter diagnostic tests found none met the current regulatory standards.

An assessment of the documentation for 30 over-the-counter diagnostic tests found none met the current regulatory standards.

The blood test is designed to detect the accumulation of amyloid protein deposits in the brain, a hallmark of Alzheimer's disease.

The company said on Thursday that most of the increase came from organic revenues while acquisitions contributed to the company's growth.

Note: This story has been updated with comments from the company's conference call to discuss its financial results. NEW YORK – Despite volume-based procurement programs and healthcare pricing reforms ...

The investment bank said that Exagen is poised for growth with a differentiated autoimmune test that outperforms conventional biomarker-based tests.

The cash deal includes ambulatory outreach laboratory services in 13 states and includes patient service centers and in-office phlebotomy sites.

The test was developed in collaboration with Eli Lilly and can be used with other clinical information to rule out Alzheimer's disease as the cause of cognitive decline.